, 19-DEL

Product ID: 19-DEL

Specification

No.	Age	Gender	Mutant gene	Mutation site	Gene Mutation Status	Mutation Type	Method	Histological diagnosis	TNM	Stage (AJCC)
19-RLN0201	35	M	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N2M0	IIIA
19-RLN0202	60	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T4N2M1	IV
19-RLN0203	64	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N0M0	IA
19-RLN0204	56	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N0M0	IA
19-RLN0205	49	M	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N0M0	IA
19-RLN0206	58	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T4N2M1	IV
19-RLN0207	66	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N0M0	IA
19-RLN0208	61	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N0M0	IA
19-RLN0209	55	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N0M0	IA
19-RLN0210	56	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma in si	T1N0M0	IA
19-RLN0211	52	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N0M0	IA
19-RLN0212	72	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N0M0	IA
19-RLN0213	59	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T2N3M0	IIIB
19-RLN0214	53	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N0M0	IA
19-RLN0215	60	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N0M0	IA
19-RLN0216	50	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T1N0M0	IA
19-RLN0217	65	M	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T2N2M0	IIIA
19-RLN0218	55	F	EGFR	19-del	Mutant typ	DEL	PCR	Mucinous / non mucin	T2N0M0	IIA
19-RLN0219	71	M	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T4N1M1	IV
19-RLN0220	63	F	EGFR	19-del	Mutant typ	DEL	PCR	Adenocarcinoma	T3N2M1	IV
L-RLN0201	53	M	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T2N0M0	IIA
L-RLN0202	47	M	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T1N0M0	IA
L-RLN0203	65	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T3N2M1	IV
L-RLN0204	65	M	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T1N0M0	IA
L-RLN0205	65	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T1N0M0	IA
L-RLN0206	64	M	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T1N0M0	IA
L-RLN0207	76	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T1N0M0	IA
L-RLN0208	53	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T1N0M0	IA
L-RLN0209	52	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T1N0M0	IA
L-RLN0210	69	M	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T4N1M0	IIIA
L-RLN0211	63	M	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T1N0M0	IA
L-RLN0212	65	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T2N2M0	IIIA
L-RLN0213	53	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma in si	T1N0M0	IA
L-RLN0214	56	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T4N1M1	IV
L-RLN0215	41	M	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma in si	T1N0M0	IA
L-RLN0216	44	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma in si	T1N0M0	IA
L-RLN0217	69	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T2N0M0	IIA
L-RLN0218	52	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T1N0M0	IA
L-RLN0219	62	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T3N1M0	IIIA
L-RLN0220	67	F	EGFR	L858R	Mutant typ	Mutation	PCR	Adenocarcinoma	T1N0M0	IA

BioCoreUSA Corporation

6024 Ridge Ave, Suite 116-236
Philadelphia PA 19128
United States

Email:
Customerservices@biocoreusa.com
Info@biocoreusa.com
TEL: 888-899 6266

SUPPORT

Delivery
Privacy Policy
Terms & Conditions
FAQs